Julio Gutierrez
Company: Altimmune
Job title: Director, Medical
Seminars:
2:45 pm Harnessing GLP-1s to Maximize MASH Treatment Effectiveness to Expand the Therapeutic Benefits of This Class of Drugs 2:45 pm
Reviewing GLP-1 mechanisms, including the unique biological actions of GLP-1 receptor agonists in targeting key pathways of MASH pathogenesis to demonstrate their potential to improve liver health to offer a novel therapeutic avenue for MASH patients Presenting GLP-1 clinical evidence in MASH patients to demonstrate significant improvements in histological endpoints and metabolic profiles to establish…Read more
day: Conf day 2
3:45 pm Panel Discussion: Expanding GLP1’s Role to Target MASH-Related Comorbidities to Improve Holistic Patient Outcomes 3:45 pm
Detailing GLP-1s effects on comorbidities to illustrate how these drugs can address a range of MASH-related comorbidities to offer a comprehensive treatment strategy to improve overall patient management Highlighting the benefits of a holistic approach to understand the advantages of using GLP-1s to manage MASH and its associated conditions to lead to better coordination of…Read more
day: Conf day 2